Evidence map›Paper›PMID 35251745›Full record

ArticleWestern Pacific surveillance and response journal : WPSAR

Enhanced event-based surveillance for imported diseases during the Tokyo 2020 Olympic and Paralympic Games.

Ayu Kasamatsu, Masayuki Ota, Tomoe Shimada, Munehisa Fukusumi, Takuya Yamagishi, Anita Samuel, Manami Nakashita, Tomohiko Ukai, Katsuki Kurosawa, Miho Urakawa and 14 more

Abstract read
In one paragraph

Article in Western Pacific surveillance and response journal : WPSAR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Epidemiology of invasive meningococcal disease, Japan, 2013 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Ayu KasamatsuField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Masayuki OtaField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Tomoe ShimadaCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
Munehisa FukusumiCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
Takuya YamagishiCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
Anita SamuelCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
Manami NakashitaField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Tomohiko UkaiField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Katsuki KurosawaField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Miho UrakawaField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Kensuke TakahashiField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Keiko TsukadaField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Akane FutamiField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Hideya InoueField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Shun OmoriField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Miho KobayashiField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Hiroko KomiyaField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Takahisa ShimadaField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Sakiko TabataField Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan.
Yuichiro YahataCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
Hajime KamiyaCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
Fumi YoshimatsuCenter for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan.
Tomimasa SunagawaCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
Tomoya SaitoCenter for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2021, the National Institute of Infectious Diseases, Japan, undertook enhanced event-based surveillance (EBS) for infectious diseases occurring overseas that have potential for importation (excluding coronavirus disease 2019 [COVID-19]) for the Tokyo 2020 Olympic and Paralympic Summer Games (the Games). The pre-existing EBS system was enhanced using the World Health Organization Epidemic Intelligence from Open Sources system and the BlueDot Epidemic Intelligence platform. The enhanced EBS before and during the Games did not detect any major public health event that would warrant action for the Games. However, information from multiple sources helped us identify events, characterize risk and improve confidence in risk assessment. The collaboration also reduced the surveillance workload of the host country, while ensuring the quality of surveillance, even during the COVID-19 pandemic.

Indexed as

Communicable DiseasesCOVID-19HumansPandemicsSARS-CoV-2Tokyo

Identifiers

PMID35251745
PMCPMC8873917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.